Highly sensitive detection of antibody nonspecific interactions using flow cytometry

Area of Science:

• Biotechnology
• Immunology
• Drug Discovery

Background:

• Antibody drug development generates numerous candidates, requiring rapid screening for drug-like properties.
• High antibody specificity, indicated by low nonspecific binding, is crucial for therapeutic success.
• Existing polyspecificity assays often lack sensitivity or rely on proprietary methods.

Purpose of the Study:

• To develop a sensitive and high-throughput assay for evaluating antibody nonspecific interactions.
• To overcome limitations of current polyspecificity detection methods.
• To facilitate the selection of drug-like antibody candidates.

Main Methods:

• Development of the PolySpecificity Particle (PSP) assay using Protein A-coated magnetic beads.
• Utilizing flow cytometry to analyze binding of polyspecificity reagents to captured antibodies at dilute concentrations (<0.02 mg/mL).
• Comparison of assay performance with established polyspecificity reagents and ovalbumin.

Main Results:

• The PSP assay demonstrates high sensitivity in detecting differences in nonspecific binding among clinical-stage antibodies.
• The assay effectively discriminates antibody polyspecificity using various reagents, with ovalbumin showing optimal performance.
• The PSP assay is significantly more sensitive than standard methods like ELISAs.

Conclusions:

• The PSP assay is a sensitive, simple, and high-throughput method for assessing antibody nonspecific interactions.
• This assay can evaluate diverse antibody formats, including IgGs, multispecific antibodies, and Fc-fusion proteins.
• The PSP assay is expected to accelerate the development of safe and effective antibody therapeutics.